PTC
ANIP icon

Petrus Trust Company’s ANI Pharmaceuticals ANIP Stock Holding History

Petrus Trust Company’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,652
Closed -$499K – 190
2025
Q2 		$499K Buy
+7,652
New +$498K 0.05% 116
2024
Q4 		– Sell
-4,342
Closed -$259K – 586
2024
Q3 		$259K Buy
4,342
+713
+20% +$43.5K 0.03% 460
2024
Q2 		$231K Hold
3,629
– – 0.02% 514
2024
Q1 		$251K Hold
3,629
– – 0.02% 501
2023
Q4 		$200K Sell
3,629
-2,122
-37% -$117K 0.02% 563
2023
Q3 		$334K Hold
5,751
– – 0.04% 350
2023
Q2 		$310K Buy
+5,751
New +$255K 0.03% 350

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return